Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Determining the effects of insulin receptor and inceptor on downstream cancer signalling pathways

EF 2022-23

Résumé
Obesity is a worldwide health challenge with millions of people around the world dying per year due to being overweight or obese. While diabetes and heart disease are the major health issues linked to obesity, people with a higher body mass index (BMI) have a greater risk of developing a number of cancers. Hyperinsulinemia, which is the overproduction of insulin, along with other obesity-related factors, is associated with development of these cancers. Broad expression of insulin receptor (IR) in human cancer raises the possibility that the insulin/IR axis might contribute towards tumorigenesis. When activated, the insulin receptor has roles in cell proliferation and survival through signalling via the MAPK/ERK and PI3K/Akt pathways. There are two isoforms of IR, IR-A and IR-B, and IR-A has been found to be upregulated in breast cancer cells. IR-A has roles in upregulating mitogenic signalling pathways and may account for resistance to insulin-like growth factor 1 receptor (IGF1R) targeted therapies. Inceptor, a membrane protein with structural similarities to IR and IGF1R, has recently been identified as a negative regulator of IR-IGF1R signalling in pancreatic ?-cells by facilitating their clathrin-mediated endocytosis. I hypothesize that inceptor impacts cancer via regulation of IR/IGF1R turnover and effects on their downstream signalling pathways. This will be investigated by producing and characterizing CRISPR/Cas9-based IR and inceptor knockout (KO) breast cancer cell lines, assessing downstream signalling effects, and identifying structure/function relationships between inceptor and IR/IGF1R. This work will further elucidate contributions of the insulin/IR axis to human cancer, towards a better understanding of cancer in the obese.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
485936
Name
McDonnell Brianna
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Determining the effects of insulin receptor and inceptor on downstream cancer signalling pathways
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Crispr; Igf1r; Inceptor; Insulin Receptor; Metabolism; Signalling
Abstract
Obesity is a worldwide health challenge with millions of people around the world dying per year due to being overweight or obese. While diabetes and heart disease are the major health issues linked to obesity, people with a higher body mass index (BMI) have a greater risk of developing a number of cancers. Hyperinsulinemia, which is the overproduction of insulin, along with other obesity-related factors, is associated with development of these cancers. Broad expression of insulin receptor (IR) in human cancer raises the possibility that the insulin/IR axis might contribute towards tumorigenesis. When activated, the insulin receptor has roles in cell proliferation and survival through signalling via the MAPK/ERK and PI3K/Akt pathways. There are two isoforms of IR, IR-A and IR-B, and IR-A has been found to be upregulated in breast cancer cells. IR-A has roles in upregulating mitogenic signalling pathways and may account for resistance to insulin-like growth factor 1 receptor (IGF1R) targeted therapies. Inceptor, a membrane protein with structural similarities to IR and IGF1R, has recently been identified as a negative regulator of IR-IGF1R signalling in pancreatic ?-cells by facilitating their clathrin-mediated endocytosis. I hypothesize that inceptor impacts cancer via regulation of IR/IGF1R turnover and effects on their downstream signalling pathways. This will be investigated by producing and characterizing CRISPR/Cas9-based IR and inceptor knockout (KO) breast cancer cell lines, assessing downstream signalling effects, and identifying structure/function relationships between inceptor and IR/IGF1R. This work will further elucidate contributions of the insulin/IR axis to human cancer, towards a better understanding of cancer in the obese.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
McDonnell, Brianna
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~